Pfizer’s Viagra Case Withers In China

Law360, New York (February 5, 2007, 12:00 AM EST) -- Pfizer Inc. has suffered a blow in its bid to protect the rights to Viagra in China, with a Beijing court ruling that the drug maker can no longer use the name Wei Ge, or “mighty brother,” to market the erectile dysfunction drug because a Chinese pharmaceutical company has already registered the brand.

The Beijing No. 1 Intermediate People's Court said Guangzhou Welman, a Chinese anti-impotency drug maker, should be allowed to keep the rights to the brand name Wei Ge because it registered the name...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.